Galapagos + CellPoint + AboundBio, Radius, Ipsen + Epizyme, DEM Bio

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/20/9c/89/209c8941-601e-2fa1-19c3-76f55af3575e/mza_14607577291171710004.jpg/600x600bb.jpg

Life Science Today

Noah Goodson, PhD

72 episodes

9 months ago

This week, I have an announcement to make. Find out more athttps://LifeScienceTodayPodcast.comAbout the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolvi...

All content for Life Science Today is the property of Noah Goodson, PhD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Education,

Business

Galapagos + CellPoint + AboundBio, Radius, Ipsen + Epizyme, DEM Bio

Life Science Today

6 minutes

3 years ago

Galapagos + CellPoint + AboundBio, Radius, Ipsen + Epizyme, DEM Bio

Double acquisition, private money, affordable deals, and a surprising $70M launchFind out more athttps://LifeScienceTodayPodcast.comStory ReferencesGalapagos + CellPoint + AboundBioRadiusIpsen + EpizymeDEM Bio About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock mar...